Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Rasa3 deficiency minimally affects thrombopoiesis but promotes severe thrombocytopenia due to integrin-dependent platelet clearance
Robert H. Lee, … , Anita Eckly, Wolfgang Bergmeier
Robert H. Lee, … , Anita Eckly, Wolfgang Bergmeier
Published March 15, 2022
Citation Information: JCI Insight. 2022;7(8):e155676. https://doi.org/10.1172/jci.insight.155676.
View: Text | PDF
Research Article Cell biology Hematology

Rasa3 deficiency minimally affects thrombopoiesis but promotes severe thrombocytopenia due to integrin-dependent platelet clearance

  • Text
  • PDF
Abstract

Platelet homeostasis is dependent on a tight regulation of both platelet production and clearance. The small GTPase Rap1 mediates platelet adhesion and hemostatic plug formation. However, Rap1 signaling is also critical for platelet homeostasis as both Rap1 deficiency and uninhibited Rap1 signaling lead to marked thrombocytopenia in mice. Here, we investigated the mechanism by which deficiency in Rasa3, a critical negative regulator of Rap1, causes macrothrombocytopenia in mice. Despite marked morphological and ultrastructural abnormalities, megakaryocytes in hypomorphic Rasa3hlb/hlb (R3hlb/hlb) or Rasa3–/– mice demonstrated robust proplatelet formation in vivo, suggesting that defective thrombopoiesis is not the main cause of thrombocytopenia. Rather, we observed that R3hlb/hlb platelets became trapped in the spleen marginal zone/red pulp interface, with evidence of platelet phagocytosis by macrophages. Clearance of mutant platelets was also observed in the liver, especially in splenectomized mice. Platelet count and platelet life span in Rasa3-mutant mice were restored by genetic or pharmacological approaches to inhibit the Rap1/talin1/αIIbβ3 integrin axis. A similar pattern of splenic clearance was observed in mice injected with anti-αIIbβ3 but not anti–glycoprotein Ibα platelet-depleting antibodies. In summary, we describe a potentially novel, integrin-based mechanism of platelet clearance that could be critical for our understanding of select inherited and acquired thrombocytopenias.

Authors

Robert H. Lee, Dorsaf Ghalloussi, Gabriel L. Harousseau, Joseph P. Kenny, Patrick A. Kramer, Fabienne Proamer, Bernhard Nieswandt, Matthew J. Flick, Christian Gachet, Caterina Casari, Anita Eckly, Wolfgang Bergmeier

×

Figure 5

Clearance of Rasa3-mutant platelets in the spleen is mediated in part by talin1 and αIIbβ3 integrin.

Options: View larger image (or click on image) Download as PowerPoint
Clearance of Rasa3-mutant platelets in the spleen is mediated in part by...
(A) Circulating platelet counts were determined by flow cytometry using whole blood from R3hlb/hlb, Talin1fl/fl Pf4-Cre+ (Tln1mKO), or R3hlb/hlb Tln1mKO double-mutant mice (n = 4–10). (B) Mice were injected i.v. with anti–GPIX-AF488 antibody (2.5 μg/mouse) on day 0 to label all circulating platelets, and then the percentage of GPIX-AF488+ platelets remaining was determined every 24 hours by flow cytometry (n = 5–6). (C) IF image of a R3hlb/hlb Tln1mKO spleen cryosection stained for platelets with anti–GPIX-AF488 (green), RPMs with anti–F4/80-AF647 (red), and nuclei with Hoechst (blue). Scale bar: 20 μm. (D) R3hlb/hlb mice were injected once per day with a blocking anti–αIIbβ3 F(ab′)2 antibody (clone 4H5, 75 μg) or saline, and platelet counts were determined before (t = 0) and after (t = 24, 48 hours) injection (n = 3–4). (E) IF images of spleen cryosections collected from WT mice 30 minutes after bolus injection with anti-αIIbβ3 (clone MWReg30) or anti-GPIbα (clone R300) platelet-depleting antibodies (2 μg/g BW), demonstrating peri-MZ accumulation of platelets with anti-αIIbβ3 but not anti-GPIbα antibodies. Cryosections were stained for platelets (green), RPMs (red), and nuclei (blue). Scale bar: 20 μm. Data shown as mean ± SEM. Statistical significance was determined using 1-way ANOVA in A or 2-way ANOVA in B and D with Bonferroni’s correction for multiple comparisons.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts